 | • レポートコード：D005-03028 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオ医薬品Cmo＆Croの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオ医薬品Cmo＆Croの種類別市場規模（生物製剤、バイオシミラー）、用途別市場規模（受託製造、受託研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Lonza、FUJIFILM Diosynth Biotechnologies U.S.A., Inc.、Inno Biologics Sdn Bhd、Boehringer Ingelheim GmbH、ProBioGen、Rentschler Biotechnologie GmbH、Samsung BioLogics、BIOMEVA GmbH、JRS Pharma (Celonic GmbH)、TOYOBO CO., LTD、WuXi Biologics.、Patheon、AbbVie Inc.、CMC Biologics、Binex Co., Ltd. ・地域別グローバル市場分析 2015年-2020年 ・バイオ医薬品Cmo＆Croの北米市場（アメリカ、カナダ、メキシコ） ・バイオ医薬品Cmo＆Croのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオ医薬品Cmo＆Croのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオ医薬品Cmo＆Croの南米市場（ブラジル、アルゼンチン） ・バイオ医薬品Cmo＆Croの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生物製剤、バイオシミラー ・用途別分析：受託製造、受託研究 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Biopharmaceutical Cmo & Cro market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biopharmaceutical Cmo & Cro market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biopharmaceutical Cmo & Cro market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharmaceutical Cmo & Cro market has been segmented into
Biologics
Biosimilars
By Application, Biopharmaceutical Cmo & Cro has been segmented into:
Contract Manufacturing
Contract Research
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceutical Cmo & Cro market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceutical Cmo & Cro markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceutical Cmo & Cro market.
The report offers in-depth assessment of the growth and other aspects of the Biopharmaceutical Cmo & Cro market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biopharmaceutical Cmo & Cro Market Share Analysis
Biopharmaceutical Cmo & Cro competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceutical Cmo & Cro sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceutical Cmo & Cro sales, revenue and market share for each player covered in this report.
The major players covered in Biopharmaceutical Cmo & Cro are:
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Inno Biologics Sdn Bhd
Boehringer Ingelheim GmbH
ProBioGen
Rentschler Biotechnologie GmbH
Samsung BioLogics
BIOMEVA GmbH
JRS Pharma (Celonic GmbH)
TOYOBO CO., LTD
WuXi Biologics.
Patheon
AbbVie Inc.
CMC Biologics
Binex Co., Ltd.
Among other players domestic and global, Biopharmaceutical Cmo & Cro market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biopharmaceutical Cmo & Cro product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biopharmaceutical Cmo & Cro, with price, sales, revenue and global market share of Biopharmaceutical Cmo & Cro in 2018 and 2019.
Chapter 3, the Biopharmaceutical Cmo & Cro competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biopharmaceutical Cmo & Cro breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biopharmaceutical Cmo & Cro market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biopharmaceutical Cmo & Cro sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Biopharmaceutical Cmo & Cro Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biopharmaceutical Cmo & Cro Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Biologics
1.2.3 Biosimilars
1.3 Market Analysis by Application
1.3.1 Overview: Global Biopharmaceutical Cmo & Cro Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Contract Manufacturing
1.3.3 Contract Research
1.4 Overview of Global Biopharmaceutical Cmo & Cro Market
1.4.1 Global Biopharmaceutical Cmo & Cro Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Lonza SWOT Analysis
2.1.4 Lonza Product and Services
2.1.5 Lonza Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
2.2.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Details
2.2.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. SWOT Analysis
2.2.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Product and Services
2.2.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Inno Biologics Sdn Bhd
2.3.1 Inno Biologics Sdn Bhd Details
2.3.2 Inno Biologics Sdn Bhd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Inno Biologics Sdn Bhd SWOT Analysis
2.3.4 Inno Biologics Sdn Bhd Product and Services
2.3.5 Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim GmbH
2.4.1 Boehringer Ingelheim GmbH Details
2.4.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim GmbH SWOT Analysis
2.4.4 Boehringer Ingelheim GmbH Product and Services
2.4.5 Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 ProBioGen
2.5.1 ProBioGen Details
2.5.2 ProBioGen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ProBioGen SWOT Analysis
2.5.4 ProBioGen Product and Services
2.5.5 ProBioGen Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Rentschler Biotechnologie GmbH
2.6.1 Rentschler Biotechnologie GmbH Details
2.6.2 Rentschler Biotechnologie GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Rentschler Biotechnologie GmbH SWOT Analysis
2.6.4 Rentschler Biotechnologie GmbH Product and Services
2.6.5 Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Samsung BioLogics
2.7.1 Samsung BioLogics Details
2.7.2 Samsung BioLogics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Samsung BioLogics SWOT Analysis
2.7.4 Samsung BioLogics Product and Services
2.7.5 Samsung BioLogics Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BIOMEVA GmbH
2.8.1 BIOMEVA GmbH Details
2.8.2 BIOMEVA GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BIOMEVA GmbH SWOT Analysis
2.8.4 BIOMEVA GmbH Product and Services
2.8.5 BIOMEVA GmbH Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 JRS Pharma (Celonic GmbH)
2.9.1 JRS Pharma (Celonic GmbH) Details
2.9.2 JRS Pharma (Celonic GmbH) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 JRS Pharma (Celonic GmbH) SWOT Analysis
2.9.4 JRS Pharma (Celonic GmbH) Product and Services
2.9.5 JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 TOYOBO CO., LTD
2.10.1 TOYOBO CO., LTD Details
2.10.2 TOYOBO CO., LTD Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 TOYOBO CO., LTD SWOT Analysis
2.10.4 TOYOBO CO., LTD Product and Services
2.10.5 TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 WuXi Biologics.
2.11.1 WuXi Biologics. Details
2.11.2 WuXi Biologics. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 WuXi Biologics. SWOT Analysis
2.11.4 WuXi Biologics. Product and Services
2.11.5 WuXi Biologics. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Patheon
2.12.1 Patheon Details
2.12.2 Patheon Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Patheon SWOT Analysis
2.12.4 Patheon Product and Services
2.12.5 Patheon Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 AbbVie Inc.
2.13.1 AbbVie Inc. Details
2.13.2 AbbVie Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AbbVie Inc. SWOT Analysis
2.13.4 AbbVie Inc. Product and Services
2.13.5 AbbVie Inc. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 CMC Biologics
2.14.1 CMC Biologics Details
2.14.2 CMC Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 CMC Biologics SWOT Analysis
2.14.4 CMC Biologics Product and Services
2.14.5 CMC Biologics Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Binex Co., Ltd.
2.15.1 Binex Co., Ltd. Details
2.15.2 Binex Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Binex Co., Ltd. SWOT Analysis
2.15.4 Binex Co., Ltd. Product and Services
2.15.5 Binex Co., Ltd. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biopharmaceutical Cmo & Cro Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biopharmaceutical Cmo & Cro Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biopharmaceutical Cmo & Cro Manufacturer Market Share in 2019
3.3.2 Top 6 Biopharmaceutical Cmo & Cro Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biopharmaceutical Cmo & Cro Sales, Revenue and Market Share by Regions
4.1.1 Global Biopharmaceutical Cmo & Cro Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biopharmaceutical Cmo & Cro Revenue and Market Share by Regions (2015-2020)
4.2 North America Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
4.3 Europe Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
4.5 South America Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biopharmaceutical Cmo & Cro Sales, Revenue and Market Share by Country
5.1.1 North America Biopharmaceutical Cmo & Cro Sales and Market Share by Country (2015-2020)
5.1.2 North America Biopharmaceutical Cmo & Cro Revenue and Market Share by Country (2015-2020)
5.2 United States Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
5.3 Canada Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biopharmaceutical Cmo & Cro Sales, Revenue and Market Share by Country
6.1.1 Europe Biopharmaceutical Cmo & Cro Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biopharmaceutical Cmo & Cro Revenue and Market Share by Country (2015-2020)
6.2 Germany Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
6.3 UK Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
6.4 France Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
6.5 Russia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
6.6 Italy Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biopharmaceutical Cmo & Cro Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biopharmaceutical Cmo & Cro Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biopharmaceutical Cmo & Cro Revenue and Market Share by Regions (2015-2020)
7.2 China Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
7.3 Japan Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
7.4 Korea Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
7.5 India Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
7.7 Australia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biopharmaceutical Cmo & Cro Sales, Revenue and Market Share by Country
8.1.1 South America Biopharmaceutical Cmo & Cro Sales and Market Share by Country (2015-2020)
8.1.2 South America Biopharmaceutical Cmo & Cro Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biopharmaceutical Cmo & Cro Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biopharmaceutical Cmo & Cro Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biopharmaceutical Cmo & Cro Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
9.3 Turkey Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biopharmaceutical Cmo & Cro Sales and Market Share by Type (2015-2020)
10.2 Global Biopharmaceutical Cmo & Cro Revenue and Market Share by Type (2015-2020)
10.3 Global Biopharmaceutical Cmo & Cro Price by Type (2015-2020)
11 Global Biopharmaceutical Cmo & Cro Market Segment by Application
11.1 Global Biopharmaceutical Cmo & Cro Sales Market Share by Application (2015-2020)
11.2 Global Biopharmaceutical Cmo & Cro Revenue Market Share by Application (2015-2020)
11.3 Global Biopharmaceutical Cmo & Cro Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biopharmaceutical Cmo & Cro Sales, Revenue and Growth Rate (2021-2025)
12.2 Biopharmaceutical Cmo & Cro Market Forecast by Regions (2021-2025)
12.2.1 North America Biopharmaceutical Cmo & Cro Market Forecast (2021-2025)
12.2.2 Europe Biopharmaceutical Cmo & Cro Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biopharmaceutical Cmo & Cro Market Forecast (2021-2025)
12.2.4 South America Biopharmaceutical Cmo & Cro Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biopharmaceutical Cmo & Cro Market Forecast (2021-2025)
12.3 Biopharmaceutical Cmo & Cro Market Forecast by Type (2021-2025)
12.3.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Type (2021-2025)
12.3.2 Global Biopharmaceutical Cmo & Cro Market Share Forecast by Type (2021-2025)
12.4 Biopharmaceutical Cmo & Cro Market Forecast by Application (2021-2025)
12.4.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Application (2021-2025)
12.4.2 Global Biopharmaceutical Cmo & Cro Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biopharmaceutical Cmo & Cro Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceutical Cmo & Cro by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceutical Cmo & Cro Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Lonza Basic Information, Manufacturing Base and Competitors
Table 8. Lonza Biopharmaceutical Cmo & Cro Major Business
Table 9. Lonza Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 10. Lonza SWOT Analysis
Table 11. Lonza Biopharmaceutical Cmo & Cro Product and Services
Table 12. Lonza Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Basic Information, Manufacturing Base and Competitors
Table 14. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Major Business
Table 15. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 16. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. SWOT Analysis
Table 17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Product and Services
Table 18. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Inno Biologics Sdn Bhd Basic Information, Manufacturing Base and Competitors
Table 20. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Major Business
Table 21. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 22. Inno Biologics Sdn Bhd SWOT Analysis
Table 23. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Product and Services
Table 24. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 26. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Major Business
Table 27. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 28. Boehringer Ingelheim GmbH SWOT Analysis
Table 29. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Product and Services
Table 30. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. ProBioGen Basic Information, Manufacturing Base and Competitors
Table 32. ProBioGen Biopharmaceutical Cmo & Cro Major Business
Table 33. ProBioGen Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 34. ProBioGen SWOT Analysis
Table 35. ProBioGen Biopharmaceutical Cmo & Cro Product and Services
Table 36. ProBioGen Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Rentschler Biotechnologie GmbH Basic Information, Manufacturing Base and Competitors
Table 38. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Major Business
Table 39. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 40. Rentschler Biotechnologie GmbH SWOT Analysis
Table 41. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Product and Services
Table 42. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Samsung BioLogics Basic Information, Manufacturing Base and Competitors
Table 44. Samsung BioLogics Biopharmaceutical Cmo & Cro Major Business
Table 45. Samsung BioLogics Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 46. Samsung BioLogics SWOT Analysis
Table 47. Samsung BioLogics Biopharmaceutical Cmo & Cro Product and Services
Table 48. Samsung BioLogics Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. BIOMEVA GmbH Basic Information, Manufacturing Base and Competitors
Table 50. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Major Business
Table 51. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 52. BIOMEVA GmbH SWOT Analysis
Table 53. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Product and Services
Table 54. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. JRS Pharma (Celonic GmbH) Basic Information, Manufacturing Base and Competitors
Table 56. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Major Business
Table 57. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 58. JRS Pharma (Celonic GmbH) SWOT Analysis
Table 59. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Product and Services
Table 60. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. TOYOBO CO., LTD Basic Information, Manufacturing Base and Competitors
Table 62. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Major Business
Table 63. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 64. TOYOBO CO., LTD SWOT Analysis
Table 65. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Product and Services
Table 66. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. WuXi Biologics. Basic Information, Manufacturing Base and Competitors
Table 68. WuXi Biologics. Biopharmaceutical Cmo & Cro Major Business
Table 69. WuXi Biologics. Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 70. WuXi Biologics. SWOT Analysis
Table 71. WuXi Biologics. Biopharmaceutical Cmo & Cro Product and Services
Table 72. WuXi Biologics. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Patheon Basic Information, Manufacturing Base and Competitors
Table 74. Patheon Biopharmaceutical Cmo & Cro Major Business
Table 75. Patheon Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 76. Patheon SWOT Analysis
Table 77. Patheon Biopharmaceutical Cmo & Cro Product and Services
Table 78. Patheon Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 80. AbbVie Inc. Biopharmaceutical Cmo & Cro Major Business
Table 81. AbbVie Inc. Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 82. AbbVie Inc. SWOT Analysis
Table 83. AbbVie Inc. Biopharmaceutical Cmo & Cro Product and Services
Table 84. AbbVie Inc. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. CMC Biologics Basic Information, Manufacturing Base and Competitors
Table 86. CMC Biologics Biopharmaceutical Cmo & Cro Major Business
Table 87. CMC Biologics Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 88. CMC Biologics SWOT Analysis
Table 89. CMC Biologics Biopharmaceutical Cmo & Cro Product and Services
Table 90. CMC Biologics Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Binex Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Major Business
Table 93. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Total Revenue (USD Million) (2017-2018)
Table 94. Binex Co., Ltd. SWOT Analysis
Table 95. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Product and Services
Table 96. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Biopharmaceutical Cmo & Cro Sales by Manufacturer (2018-2019) (K MT)
Table 98. Global Biopharmaceutical Cmo & Cro Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Biopharmaceutical Cmo & Cro Sales by Regions (2015-2020) (K MT)
Table 100. Global Biopharmaceutical Cmo & Cro Sales Market Share by Regions (2015-2020)
Table 101. Global Biopharmaceutical Cmo & Cro Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Biopharmaceutical Cmo & Cro Sales by Countries (2015-2020) (K MT)
Table 103. North America Biopharmaceutical Cmo & Cro Sales Market Share by Countries (2015-2020)
Table 104. North America Biopharmaceutical Cmo & Cro Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Biopharmaceutical Cmo & Cro Revenue Market Share by Countries (2015-2020)
Table 106. Europe Biopharmaceutical Cmo & Cro Sales by Countries (2015-2020) (K MT)
Table 107. Europe Biopharmaceutical Cmo & Cro Sales Market Share by Countries (2015-2020)
Table 108. Europe Biopharmaceutical Cmo & Cro Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Biopharmaceutical Cmo & Cro Sales by Regions (2015-2020) (K MT)
Table 110. Asia-Pacific Biopharmaceutical Cmo & Cro Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Biopharmaceutical Cmo & Cro Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Biopharmaceutical Cmo & Cro Sales by Countries (2015-2020) (K MT)
Table 113. South America Biopharmaceutical Cmo & Cro Sales Market Share by Countries (2015-2020)
Table 114. South America Biopharmaceutical Cmo & Cro Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Biopharmaceutical Cmo & Cro Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Biopharmaceutical Cmo & Cro Sales by Countries (2015-2020) (K MT)
Table 117. Middle East & Africa Biopharmaceutical Cmo & Cro Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Biopharmaceutical Cmo & Cro Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Biopharmaceutical Cmo & Cro Revenue Market Share by Countries (2015-2020)
Table 120. Global Biopharmaceutical Cmo & Cro Sales by Type (2015-2020) (K MT)
Table 121. Global Biopharmaceutical Cmo & Cro Sales Share by Type (2015-2020)
Table 122. Global Biopharmaceutical Cmo & Cro Revenue by Type (2015-2020) (USD Million)
Table 123. Global Biopharmaceutical Cmo & Cro Revenue Share by Type (2015-2020)
Table 124. Global Biopharmaceutical Cmo & Cro Sales by Application (2015-2020) (K MT)
Table 125. Global Biopharmaceutical Cmo & Cro Sales Share by Application (2015-2020)
Table 126. Global Biopharmaceutical Cmo & Cro Sales Forecast by Regions (2021-2025) (K MT)
Table 127. Global Biopharmaceutical Cmo & Cro Market Share Forecast by Regions (2021-2025)
Table 128. Global Biopharmaceutical Cmo & Cro Sales Forecast by Type (2021-2025) (K MT)
Table 129. Global Biopharmaceutical Cmo & Cro Market Share Forecast by Type (2021-2025)
Table 130. Global Biopharmaceutical Cmo & Cro Sales Forecast by Application (2021-2025)
Table 131. Global Biopharmaceutical Cmo & Cro Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biopharmaceutical Cmo & Cro Picture
Figure 2. Global Sales Market Share of Biopharmaceutical Cmo & Cro by Type in 2019
Figure 3. Biologics Picture
Figure 4. Biosimilars Picture
Figure 5. Biopharmaceutical Cmo & Cro Sales Market Share by Application in 2018
Figure 6. Contract Manufacturing Picture
Figure 7. Contract Research Picture
Figure 8. Global Biopharmaceutical Cmo & Cro Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Biopharmaceutical Cmo & Cro Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Biopharmaceutical Cmo & Cro Sales Market Share by Manufacturer in 2019
Figure 29. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Biopharmaceutical Cmo & Cro Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Biopharmaceutical Cmo & Cro Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 34. Global Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Regions (2015-2020)
Figure 36. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Regions in 2018
Figure 37. North America Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
Figure 38. Europe Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
Figure 40. South America Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020)
Figure 42. North America Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Biopharmaceutical Cmo & Cro Sales Market Share by Countries (2015-2020)
Figure 44. North America Biopharmaceutical Cmo & Cro Sales Market Share by Countries in 2018
Figure 45. North America Biopharmaceutical Cmo & Cro Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Biopharmaceutical Cmo & Cro Revenue Market Share by Countries in 2018
Figure 47. United States Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 48. Canada Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Mexico Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Europe Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Biopharmaceutical Cmo & Cro Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Biopharmaceutical Cmo & Cro Revenue Market Share by Countries in 2019
Figure 53. Germany Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 54. UK Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 55. France Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Russia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Italy Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Asia-Pacific Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Biopharmaceutical Cmo & Cro Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Biopharmaceutical Cmo & Cro Revenue Market Share by Regions 2019
Figure 61. China Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Japan Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Korea Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 64. India Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Southeast Asia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 66. South America Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Biopharmaceutical Cmo & Cro Sales Market Share by Countries in 2019
Figure 68. South America Biopharmaceutical Cmo & Cro Revenue Market Share by Countries in 2019
Figure 69. Brazil Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Argentina Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Middle East and Africa Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Biopharmaceutical Cmo & Cro Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Biopharmaceutical Cmo & Cro Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Biopharmaceutical Cmo & Cro Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Egypt Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Turkey Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 78. South Africa Biopharmaceutical Cmo & Cro Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Global Biopharmaceutical Cmo & Cro Sales and Growth Rate (2021-2025) (K MT)
Figure 80. Global Biopharmaceutical Cmo & Cro Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Biopharmaceutical Cmo & Cro Market Forecast (2021-2025) (K MT)
Figure 82. Europe Sales Biopharmaceutical Cmo & Cro Market Forecast (2021-2025) (K MT)
Figure 83. Asia-Pacific Sales Biopharmaceutical Cmo & Cro Market Forecast (2021-2025) (K MT)
Figure 84. South America Sales Biopharmaceutical Cmo & Cro Market Forecast (2021-2025) (K MT)
Figure 85. Middle East & Africa Sales Biopharmaceutical Cmo & Cro Market Forecast (2021-2025) (K MT)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
バイオ医薬品ロジスティックの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Biopharmaceutical Logistic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 91660 million by 2025, from USD 79160 million in 2019. The Bio…- バイオシミラー/バイオ後続品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biosimilars/Follow-on-Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biosimilars/F…
- 生物製剤及びバイオシミラーの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019. The Bi…
- バイオシミラーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.2% in the forecast period of 2020 to 2025 and will expected to reach USD 9643.4 million by 2025, from USD 5111 million in 2019. The Biosimilars market report…
- 商用玄関マットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Commercial Entrance Mat market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Commercial Entrance M…